Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v2-FR
Language English French
Date Updated 2020-10-30 2020-10-29
Drug Identification Number 02240114 02240114
Brand name FRAXIPARINE FORTE FRAXIPARINE FORTE
Common or Proper name Fraxiparine® Forte (nadroparin calcium injection (1.0 mL)) Fraxiparine® Forte (nadroparin calcium injection (1.0 mL))
Company Name ASPEN PHARMACARE CANADA INC. ASPEN PHARMACARE CANADA INC.
Ingredients NADROPARIN CALCIUM NADROPARIN CALCIUM
Strength(s) 19000UNIT 19000UNIT
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS
Packaging size 10 PF Syringe 10 PF Syringe
ATC code B01AB B01AB
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2020-10-29 2020-10-29
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments n/a n/a
Health Canada comments